Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-20-052268

SVP and General Counsel sold 2,880 shares at an average $47.78 ($137,596)

  • SVP and General Counsel acquired 2,880 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Taylor Stacy L SVP and General Counsel 2020-09-24 Option exercise +1,109 $7.80 $8,650 2,409 D
Taylor Stacy L SVP and General Counsel 2020-09-24 Option exercise +1,771 $6.55 $11,600 4,180 D
Taylor Stacy L SVP and General Counsel 2020-09-24 Sale −2,284 $47.59 $108,696 1,896 D
Taylor Stacy L SVP and General Counsel 2020-09-24 Sale −596 $48.49 $28,900 1,300 D
Derivatives
Taylor Stacy L SVP and General Counsel 2020-09-24 Option exercise · Stock Option (Right to Buy) −1,109 36,145 D
Taylor Stacy L SVP and General Counsel 2020-09-24 Option exercise · Stock Option (Right to Buy) −1,771 31,875 D
Open-market sales · 2,880 sh · avg $47.78 · $137,596
Loading xslF345X03/doc4.xml…